cholestyramine resin has been researched along with Metabolic Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheen, AJ | 1 |
Gylling, H; Miettinen, TA; Parto, K | 1 |
Morrissey, KP | 1 |
Edwards, IR; Frenk, E; Walker, AE | 1 |
Dietschy, JM; Schiff, ER | 1 |
Fromm, H; Hofmann, AF; Smith, LH | 1 |
3 review(s) available for cholestyramine resin and Metabolic Diseases
Article | Year |
---|---|
Current concepts of gallstone formation.
Topics: Animals; Bile; Bile Acids and Salts; Cholecystectomy; Cholelithiasis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet; Gallbladder; Hormones; Humans; Metabolic Diseases; Nicotinic Acids; Phenobarbital; Phosphatidylcholines; Phospholipids; Thyroxine | 1975 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins; Metabolic Diseases; Nicotinic Acids; Triglycerides; Xanthomatosis | 1972 |
Steatorrhea associated with disordered bile acid metabolism. Micellar phase defects.
Topics: Bacteroides; Bile Acids and Salts; Biliary Tract Diseases; Blind Loop Syndrome; Celiac Disease; Cholestyramine Resin; Diagnosis, Differential; Digestion; Escherichia coli; Fatty Acids; Humans; Ileum; Intestinal Diseases; Intestinal Obstruction; Intrinsic Factor; Lipid Metabolism; Liver Circulation; Malabsorption Syndromes; Metabolic Diseases; Triglycerides; Vitamin B 12 | 1969 |
3 other study(ies) available for cholestyramine resin and Metabolic Diseases
Article | Year |
---|---|
[Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
Topics: Acarbose; Anion Exchange Resins; Anti-Obesity Agents; Cholestyramine Resin; Diabetes Mellitus; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Intestine, Small; Lactones; Lipase; Metabolic Diseases; Orlistat; Trisaccharides | 1998 |
[First Finnish phytosterolemia families have been identified].
Topics: Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Finland; Humans; Male; Metabolic Diseases; Pedigree; Phytosterols | 1999 |
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome.
Topics: Adult; Aged; Bile Acids and Salts; Cholestyramine Resin; Female; Humans; Ileum; Intestinal Diseases; Kidney Calculi; Male; Metabolic Diseases; Middle Aged; Oxalates; Urography | 1972 |